Antennary fucosylations in plasma glycoproteins have been proposed to be a key biomarker for differentiating MODY patients. An international research project led by Ludger and Quadram to quantify fucosylation levels in patients found a good correlation and supports the development of a clinical diagnostic test in primary care settings.

Link to paper: https://link-springer-com.manchester.idm.oclc.org/article/10.1007/s10719-021-09992-w